chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I received covid 19 vaccine on the moring of 9/21/2022 around 11:00 am in left arm. upon awakening on 09/22/2022 when combing my hair for the morning i noted a significant amount of hair shedding falling on the floor. Upon further looking I noted on the very top center of head a patch of hair was gone, about dime size. On 9/23/2022 awaken with some itching and burning in the top scalp and noted that the patch of hair loss had extended further down and more excesssive shedding continued. I took morning meds which includes benadryl, which relieved the itching and burning, washed hair with cool water. The hair continue to shed and have periodic burning of my scalp. I have appt scheduled with doctor on 10/27/2022
Hives, itching and racing heart. Epi and Benadryl were given.
feel bad; flare up about a week after receiving the injection and weeks have gone by and its getting worse; feels tired; muscle aches; had a temperature, low grade fever; has a mild case of the flu; Initial information received on 18-Oct-2019 regarding an unsolicited valid non-serious case received from a consumer/non-hcp.  This case involves a 72 years old female patient who was feel bad, flare up about a week after receiving the injection and weeks have gone by and its getting worse, feels tired, muscle aches, had a temperature, low grade fever and has a mild case of the flu, while she received vaccines PREVNAR 13, SHINGRIX and INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 24-Sep-2019, the patient received a dose of suspect SHINGRIX not produced by Sanofi Pasteur lot number not reported via unknown route in unknown administration site.  On 24-Sep-2019, the patient received a dose of suspect PREVNAR 13 not produced by Sanofi Pasteur lot number not reported via unknown route in unknown administration site.  On 24-Sep-2019, the patient received a dose of suspect INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE lot number not reported via unknown route in unknown administration site.  In the first week or so there no pain at the injection site or any other problems.  On an unknown date, the patient developed a non-serious feel bad (feeling abnormal), flare up about a week after receiving the injection and weeks have gone by and its getting worse (arthritis), feels tired (fatigue), muscle aches (myalgia), had a temperature, low grade fever (pyrexia) and has a mild case of the flu (influenza like illness) (Unknown latency) following the administration of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE, SHINGRIX and PREVNAR 13.  (Other relevant tests included no lab data.)  Final diagnosis was Mild has a mild case of the flu, had a temperature, low grade fever, muscle aches, feels tired, flare up about a week after receiving the injection and weeks have gone by and its getting worse and feel bad.   It was not reported if the patient received a corrective treatment.  The outcome of the event was reported as Unknown for all the events.  Information on the batch number was requested.
Neuropathy; Fever; Brain fog; Allergies; Chills; Sore throat; Fatigue; Insomnia/Insomnia got worse; Liver enzymes/liver enzymes got worse; This is a spontaneous report from a contactable nurse (patient). A 60-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration on 15May2021 (Batch/Lot number was not reported) as 2nd dose, single for covid-19 immunisation. Medical history included Epstein-Barr, Covid-19 from Mar2020, long haul Covid 19 from Mar2020. The patient received the first dose of bnt162b2, via an unspecified route of administration on 24Apr2021 (Batch/Lot number was not reported) for covid-19 immunisation. The patient's concomitant medications were not reported. Clinical course: She was diagnosed with covid in Mar2020 and had "long haulers syndrome" still having symptoms, like fever, brain fog, neuropathy , allergies ,chills, sore throat, fatigue ( gone away but came back after the second dose) insomnia and liver enzymes, insomnia and liver enzymes got worse with the second dose. It was stated "long haulers " were cured with the covid vaccine. Patient was taking anti-inflammatory and antiviral medications before the vaccine and took in between the first and second dose of the covid vaccine. It was stated that prior to getting the first dose of the vaccine some symptoms of her Covid 19 had gone away finally. It was stated that she was on anti-inflammatory and anti-viral medications for Epstein Barr. She stopped them before she took the vaccine. She went back on them for about a week in between the first and second dose of the vaccine. She then stopped them again before the second dose. Reporter seriousness for events was provided as unspecified. The outcome of events was unknown.   Information on the lot/batch number has been requested.; Sender's Comments: Based on the information provided, known drug safety profile and plausible temporal association, the causality between BNT162B2 and the event neuropathy cannot be completely excluded.  The impact of this report on the benefit-risk profile of the Pfizer product and on the conduct of the study is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to  committees. and investigators, as appropriate.
Patient began feeling tired with headaches and vomiting had fever but not sure what temp was. Took child to Dr. next day. Dr states not sure of the cause of symptoms could be viral. Pt has history of ITPP. Platelets were tested and WNL.
no additional AE; expired dose of MMRII was administered; This spontaneous report was received from a pharmacist and refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided.  On 03-AUG-2020, the patient was vaccinated with expired dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (recombinant human albumin (rHA)) (M-M-R II) lot # R019978 established to be valid, expiration date 11-JUL-2020 (dose and route of administration were not reported) for prophylaxis. There was no temperature excursion. No additional adverse events were reported. The outcome of the event was unknown.   This is a non-valid report due to lack of the patient's identifiers.
Patient reported feeling fine until taking a shower about 4pm then felt dizzy.  Went to doctor & was prescribed meclizine for dizziness.
Systemic: Dizziness / Lightheadness-Medium, Additional Details: After administration of moderna booster shot patient said she felt light headed. Patient was advised to stay seated and put her head between her knees. After a few minutes patient was offered purified water from the pharmacy which she drank. She stated that she was startled by the shot and the 'pinch' was unexpected. After 2 minutes she said that she felt better but we still asked her to stay seated for monitoring. After approximately 30 minutes she stated she felt better stood slowly and left.
Both my father and my mother took your Moderna Covid vaccine and both died a few weeks later; This spontaneous case was reported by a consumer and describes the occurrence of DEATH (Both my father and my mother took your Moderna Covid vaccine and both died a few weeks later) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. Death occurred on an unknown date The cause of death was not reported. It is unknown if an autopsy was performed. Not Provided          No concomitant products were reported. No treatment drugs were reported.  Company Comment: This case concerns a male patient (age not provided) with no relevant medical history, who experienced the unexpected event of Death (Nos). The event occurred approximately few weeks (unspecified) after a dose of mRNA-1273 (Moderna Covid-19 vaccine), It's unknwon if it was the first or second dose. The rechallenge was not applicable. Limited information provided precludes a completed medical or causal assessment of this case. The benefit-risk relationship of mRNA-1273 (Moderna Covid-19 vaccine) is not affected by this report.   This case was linked to MOD-2021-370921 (Patient Link).; Sender's Comments: This case concerns a male patient (age not provided) with no relevant medical history, who experienced the unexpected event of Death (Nos). The event occurred approximately few weeks (unspecified) after a dose of mRNA-1273 (Moderna Covid-19 vaccine), It's unknwon if it was the first or second dose. The rechallenge was not applicable. Limited information provided precludes a completed medical or causal assessment of this case. The benefit-risk relationship of mRNA-1273 (Moderna Covid-19 vaccine) is not affected by this report.; Reported Cause(s) of Death: Unknown cause of death
Began having pain and mild erythema at the vaccine site a day or two after the vaccination. It persisted until a visit today.
Headache; Heart was beating me at about 100 bpm; Shivering; This case was reported by a consumer via interactive digital media and described the occurrence of heart rate increased in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On 5th August 2020, the patient received the 2nd dose of Shingrix. On 6th August 2020, 1 days after receiving Shingrix, the patient experienced headache. In August 2020, the patient experienced heart rate increased and shivering. On an unknown date, the outcome of the heart rate increased, shivering and headache were unknown.   It was unknown if the reporter considered the heart rate increased, shivering and headache to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but it was selected as adult as per the vaccine indication. The patient received Shingrix and heart was beating at about 100 bpm, shivering a bit and did had headache. The reporter asked how long would those last or was that it just a day before date of reporting.
Patient claims vaccine left her in pain for over one month.  Pain is in left upper arm and radiates up to neck.
Developed hives 1 day after vaccines given. Apparently developed hives after 1st set of immunizations but parent did not report.  Vaccines administered 10/9/07 about 2pm and mom noted hives this morning 10/10/07.  Saw Dr at 9am 10/10/07 and treated with benadryl. mom called back at 4pm stating hives started again about 5 hrs after last dose of benadryl and will now be treated with prednisone.
Unspecific adverse event; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Unspecific adverse event) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Unspecific adverse event). At the time of the report, VACCINATION COMPLICATION (Unspecific adverse event) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported. Treatment information not provided.
Case completed Covid vaccine series on 3/3/2021, then was admitted to hospital on 8/18/2021 for Covid related complications of  comorbidities.
red/inflamed around injection site; painful arm (couldn't press on it with out pain); sore up through the shoulder and neck; skin hurt (was very sensitive); slight itching;  nauseous (only for a day) other symptoms lasted about 3 days.  One week later exactly injection site became inflamed and very itchy.
2200 - resident was heard coughing and retching. Vomited his dinner.  2220 - Difficulty breathing and extremities cyanotic 2230 - resident unresponsive, CPR initiated, 911 notified. 2245 -  EMT arrived. AED applied, IV access, Epinephrine administered, intubated at 2302.  2312 - resident pronounced dead
Patient reported feeling "funny", became clammy and cool, pale for several minutes. Patient reports similar symptoms previously with other injections.
The 2nd shot very bad migraine; chills; sore arm; swollen armpit; swollen breast all right side, very painful; swollen breast all right side, very painful; couldn't sleep; constance ache and shooting pain to my nipple on this right side; back swollen; This is a spontaneous report from a contactable consumer (patient). A 56-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EW0170), dose 2 via an unspecified route of administration, administered in Arm Right on 27Apr2021 14:00 (at the age of 56-year) as 2nd dose, 0.3 ml single dose for COVID-19 immunization. Medical history was none provided (Patient history: No). Concomitant medication(s) included LISINOPRIL, OMEPRAZOLE; fluticasone propionate (FLONASE [FLUTICASONE PROPIONATE]) and LORATADINE taken for an unspecified indication, start and stop date were not reported (received within 2 weeks of vaccination). The patient previously received first dose of BNT162B2 (Batch/Lot Number: EW0158) via an unspecified route of administration, administered in Arm left on Apr2021 02:00 PM (at the age of 56-year), 0.3 ml for COVID-19 immunization and experienced migraine, sore arm on the left side the 1st shot. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Facility where the most recent COVID-19 vaccine was administered was other. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Patient stated, both shots very bad migraine a mile sore arm on the left side the 1st shot. The 2nd shot very bad migraine chills and sore arm (29Apr2021 at 12:00) Wednesday the day after. Thursday morning 2nd shot swollen armpit, swollen breast all right side, very painful all day Thursdays all night thursday couldn't sleep (29Apr2021 12:00). Friday the swelling had my right side to the center of my back swollen (2021). Call my doctor went in that friday afternoon she stated it was a reaction to the shot my lymph Nodes. that Saturday and Sunday I couldn't put my bra on due to the swelling. The medication I was giving help some with the swelling and pain. On Monday the next the swelling is not the same but as of today I am still swollen and have a different pain it's more of a constance ache and shooting pain to my nipple on this right side (2021). armpit and breast very swollen. Treatment (Medication) was used for adverse events. Patient visited Doctor or other healthcare professional office/clinic for events. Therapeutic measures were taken as a result of the 2nd shot very bad migraine, chills, sore arm, swollen armpit, swollen breast all right side, very painful , couldn't sleep, constance ache and shooting pain to my nipple on this right side, back swollen. The outcome of events was not recovered.  No follow-up attempts are needed. No further information is expected.
Discovered that the dose given was from an unconstituted vial of vaccine.  Patient had left the Pharmacy  and was fine after having been observed in the pharmacy post vaccine. Stated he felt fine at the time of discharge. Patient was notified on 02/28/2022 shortly after he had left the pharmacy per the pharmacist and informed that he had received an unconstituted dose of the Pfizer Covid 19 vaccine,  Was informed that he should monitor for increased side-effects and contact his physician if any concerns..
sore arm; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (sore arm) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Previously administered products included for an unreported indication: COVID-19 VACCINE (received first dose of Moderna Covid-19 vaccine mRNA-1273) on 12-Mar-2021.   On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On an unknown date, the patient experienced MYALGIA (sore arm). At the time of the report, MYALGIA (sore arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to US-MODERNATX, INC.-MOD-2021-079429, US-MODERNATX, INC.-MOD-2021-079291, US-MODERNATX, INC.-MOD-2021-079302, US-MODERNATX, INC.-MOD-2021-079392 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-079429: US-MODERNATX, INC.-MOD-2021-079291: US-MODERNATX, INC.-MOD-2021-079302: US-MODERNATX, INC.-MOD-2021-079392:
Large hot welt, swelling, pt has reported muscle twitching and spasms in arm (left).
he felt just a little bad; This is a spontaneous report received from a contactable reporter(s) (Other HCP).  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: FEELING ABNORMAL (non-serious), outcome "recovered", described as "he felt just a little bad". No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.  Additional information: PT reports family member with side effects of COVID vaccine PT: Well, somebody said that, if I take it, I need to take Tylenol, which would, you know. But, his brother took his first one and he said he felt just a little bad, but he rested and he was fine.  Action taken: unknown, Outcome: unknown, Causality: related   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
LEFT BELLS PALSY 12/2/2022  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
NORMAL SIDE EFFECTS AFTER THE BOOSTER ON 12-3(SORE ARM, HEADACHE, ETC.) BUT REALLY DIDN'T FEEL WELL LATER IN THE WEEK AND BY 12-12 MY HUSBAND DROVE ME TO THE ER WITH CHEST PAIN I COULD NO LONGER TOLERATE.  I WAS DIAGNOSED WITH PERICARDIAL EFFUSION CAUSED BY THE VACCINE.   MY FIRST TWO VACCINES WERE PFIZER (3-8-2021 AND 3-30-2021).
Initially reported numbness and tingling of lips and ringer after first dose of vaccine. She was given Benadryl 50mg IM. Within 15 seconds she reported not feeling well. Then she started seizing for about 30 seconds. Initial BP 148/88 and pulse ox 98.  After 5 mins BP of 125/77 and pulse ox 99%. Patient regained consciousness, was A&O x3 but felt weak/tired. She was transported to the hospital.
optical migraine; Tiredness; headaches; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A female patient in her 50's received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Optical migraine" (unspecified if ongoing), notes: Optical migraine: , Has experienced them before. The patient's concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary immunization series completed, Manufacturer: Unknown), for COVID-19 Immunization. The following information was reported: OPHTHALMIC MIGRAINE (non-serious), 3 days after the suspect product(s) administration, outcome "unknown", described as "optical migraine"; FATIGUE (non-serious), outcome "unknown", described as "Tiredness"; HEADACHE (non-serious), outcome "unknown", described as "headaches". Additional information: Patient was approximately around 54 years-old. After reporters last COVID-19 booster, she experienced tiredness, headaches and, a 3 days later, optical migraine.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
That evening I began having a bad headache and body aches.  Was exhausted needed bed rest for 2 days.  Felt better, then one week later began getting a headache and nasal congestion - then next morning my ears were affected - Pressure and headache, sounds of a million bees buzzing.  The Moderna booster shot had affected my under control Menieres disease.  Felt like I had a bad cold but pressure on ears did not cease.  Began taking cold medication for relief another 2 days in bed and slowly the sounds are less and the pressure is now only on my right ear.
No further AE; temperature excursion involving multiple lot numbers for GARDASIL 9, MMR II, ROTATEQ, and RECOMBIV AX. Many of the vaccines have been administered to patients; This spontaneous report was received from a practice manger and refers to a patient of unknown age and gender. The patient's pertinent medical history, drug reactions, allergies and concomitant medications were not reported.  On 19-AUG-2020, the patient was vaccinated with improperly stored dose of hepatitis b vaccine (recombinant) (RECOMBIVAX HB) lot #S022584, expiration date: 31-OCT-2020, dose: 1 injection (exact dose, dose #, route of administration and anatomical location were not reported) for prophylaxis.  The temperature excursion took place on 04-AUG-2020 and was as follows: below 2 Celsius degree (C) (1.1 C) for 27 hours and 45 minutes and above 9 Celsius degrees (9 C) for 1 hour and 15 minutes. There were no previous excursions reported. The digital data logger was involved. No further adverse events (AE) or product quality complain (PQC) were reported.  This is one of multiple reports received from the same reporter. combinationproductreport: Yes; brandname: RECOMBIVAX HB SYRINGE (DEVICE); commondevicename: Hepatitis B Vaccine (Recombinant); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: S022584; expirationdate: 31-OCT-2021; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; evaluatedbymfr: Not returned to manufacturer; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability; Sender's Comments:  US-009507513-2010USA001083:Same Reporter
pt recv vax 6OCT95 & 25JAN96 pt devel a rash on face (2 to 3 lesions), on back & chest & a low grade fever;
Patient got an expired dose of Bexsero; This case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 16-year-old male patient who received Men B NVS (Bexsero) (batch number abxb39aa, expiry date 31st July 2022) for prophylaxis.   Co-suspect products included meningococcal B recom vaccine + aloh + omv pre-filled syringe device (Bexsero Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 15th September 2022, the patient received Bexsero and Bexsero Pre-Filled Syringe Device. On 15th September 2022, unknown after receiving Bexsero and Bexsero Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 15-SEP-2022 Reporter's comment: The nurse reported that the patient was administrated Bexsero which was expired on July 2022. No adverse event was reported. The reporter consent to follow up. Additional Supportive Information: The patient received an expired dose of Bexsero, which led to expired vaccine used.